BUZZ-Nano-X Imaging slides after $15 mln direct stock deal
Nano-X Imaging's shares fell 8.3% after announcing a $15 million direct stock deal with an institutional investor, selling ~3.8 million shares at $3.92 each. The capital raise aims to strengthen the balance sheet and support growth initiatives. Despite the drop, the stock is up 41% over the past week. The company reported Q3 revenue growth and expects 2026 revenue of $35 million. All analysts covering the stock are bullish with a median price target of $7.50.
Shares of medical imaging tech firm Nano-X Imaging (NNOX.O) down 8.3% to $4 early Mon after equity raise
Israel-based NNOX said on Sun it ~3.8 mln shares to a single institutional investor for gross proceeds of ~$15 mln for working capital, general purposes
Purchase price equates to about $3.92. Stock on Fri closed up 26% at $4.36
CEO Erez Meltzer says
capital raise further strengthens balance sheet, accelerates growth initiatives including advancing technologies, expanding market presence and enhancing AI infrastructure
Early Thurs, co Q3 rev increased to $3.4 mln from $3 mln a year ago, and said expects 2026 rev of $35 mln
Early Weds, co said VasoHealthcare IT, a U.S.-based healthcare information technology provider, from Vaso Corp (VASO.PK)
for up to $800,000
NNOX has ~65.38 mln shares outstanding, per LSEG data
Including the move on the session, stock up about 41% over the past week since hitting intraday record low of $2.78 last Mon
All 4 analysts covering NNOX are bullish with median PT of $7.50 - LSEG (Lance Tupper is a Reuters market analyst. The views expressed are his own)
